1 de Carvalho FL, "Voiding dysfunction in patients with neuromyelitis optica spectrum disorders" 35 : 39-43, 2016
2 Trebst C, "Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)" 261 : 1-16, 2014
3 de Seze M, "The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines" 13 : 915-928, 2007
4 Jacob A, "The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom" 260 : 2134-2137, 2013
5 Wingerchuk DM, "The clinical course of neuromyelitis optica (Devic's syndrome)" 53 : 1107-1114, 1999
6 Nortvedt MW, "Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction" 7 : 231-235, 2001
7 McDonald WI, "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis" 50 : 121-127, 2001
8 DeVivo MJ, "Recent trends in mortality and causes of death among persons with spinal cord injury" 80 : 1411-1419, 1999
9 Kurtzke JF, "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)" 33 : 1444-1452, 1983
10 Allbutt TC, "On the ophthalmoscopic signs of spinal disease" 95 : 76-78, 1870
1 de Carvalho FL, "Voiding dysfunction in patients with neuromyelitis optica spectrum disorders" 35 : 39-43, 2016
2 Trebst C, "Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)" 261 : 1-16, 2014
3 de Seze M, "The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines" 13 : 915-928, 2007
4 Jacob A, "The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom" 260 : 2134-2137, 2013
5 Wingerchuk DM, "The clinical course of neuromyelitis optica (Devic's syndrome)" 53 : 1107-1114, 1999
6 Nortvedt MW, "Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction" 7 : 231-235, 2001
7 McDonald WI, "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis" 50 : 121-127, 2001
8 DeVivo MJ, "Recent trends in mortality and causes of death among persons with spinal cord injury" 80 : 1411-1419, 1999
9 Kurtzke JF, "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)" 33 : 1444-1452, 1983
10 Allbutt TC, "On the ophthalmoscopic signs of spinal disease" 95 : 76-78, 1870
11 Bart S, "Lower urinary tract dysfunction and multiple sclerosis" 17 : 358-364, 2007
12 McKinley WO, "Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis" 80 : 1402-1410, 1999
13 Wingerchuk DM, "International consensus diagnostic criteria for neuromyelitis optica spectrum disorders" 85 : 177-189, 2015
14 Vitkova M, "Health-related quality of life in multiple sclerosis patients with bladder, bowel and sexual dysfunction" 36 : 987-992, 2014
15 Ruffion A, "Groupe d'Etudes de Neuro-Urologie de Langue Francaise (GENULF) guidelines for the management of spinal cord injury and spina bifida patients" 17 : 631-633, 2007
16 Schafer W, "Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies" 21 : 261-274, 2002
17 Mealy MA, "Epidemiology of neuromyelitis optica in the United States: a multicenter analysis" 69 : 1176-1180, 2012
18 Drori T, "Diagnosis and classification of neuromyelitis optica (Devic's syndrome)" 13 : 531-533, 2014
19 Papais-Alvarenga RM, "Clinical course of optic neuritis in patients with relapsing neuromyelitis optica" 126 : 12-16, 2008
20 Ghezzi A, "Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica" 251 : 47-52, 2004
21 Amarenco G, "Clinical and urodynamic evaluations of urinary disorders in multiple sclerosis" 57 : 277-287, 2014
22 Mutch K, "Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder" 4 : 614-618, 2015
23 Gajewski JB, "An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD)" 37 : 1152-1161, 2018
24 Lennon VA, "A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis" 364 : 2106-2112, 2004